🔎 Trials Near Me

Akèy › Gliom Difize Entrinsik Pon › North Carolina › Durham

Etid klinik pou Gliom Difize Entrinsik Pon nan Durham, NC

9 etid pou Gliom Difize Entrinsik Pon ap chèche patisipan nan sit nan ak bò kote Durham (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas

Ap rekriteFaz 2
  • Duke University Medical Center, Durham
12 Months – 39 Years · Tout sèks · Mizajou Sep 21, 2026 · NCT06838676

CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

Ap rekriteFaz 1/2
  • Duke University Medical Center, Durham
12 Months – 21 Years · Tout sèks · Mizajou Sep 11, 2026 · NCT04870944

Targeted Pediatric High-Grade Glioma Therapy

Ap rekriteEtid obsèvasyon
  • Duke University Health System, Durham
12 Months – 39 Years · Tout sèks · Mizajou Sep 8, 2026 · NCT05839379

Study of Olutasidenib and Temozolomide in HGG

Ap rekriteFaz 2
  • Duke University Health System, Durham
Laj 12 a 39 · Tout sèks · Mizajou Sep 1, 2026 · NCT06161974

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

Ap rekriteFaz 2
  • Duke Cancer Center, Durham
Laj 3 a 39 · Tout sèks · Mizajou Aug 24, 2026 · NCT05096481

Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion

Ap rekriteFaz 1 bonèVolontè an sante akeyi
  • Duke University Health System, Durham
Laj 1 a 21 · Tout sèks · Mizajou Jun 29, 2026 · NCT06333899

Combination Therapy for the Treatment of Diffuse Midline Gliomas

Ap rekriteFaz 2
  • Duke University, Durham
Laj 2 a 39 · Tout sèks · Mizajou Jun 26, 2026 · NCT05009992

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

Ap rekriteFaz 2
  • Duke University Health System, Durham
12 Months – 39 Years · Tout sèks · Mizajou May 29, 2026 · NCT05843253

A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion

Ap rekriteFaz 1 bonè
  • Duke University Health System, Durham
Jiska laj 21 · Tout sèks · Mizajou Mar 18, 2026 · NCT04655404

Etid Gliom Difize Entrinsik Pon nan lòt vil

Lòt etid nan Durham

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.